Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025
Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs
Seeking Alpha / 2 hours from now 1 Views
Win-Odds Analysis Presented at American Society of Nephrology Kidney Week 2025
Comments